Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2B+, returning 12,325.1%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,325.15% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,599.45% |
Cidara Therapeutics (CDTX) | 712.58% |
Celcuity LLC (CELC) | 677% |
Terns Pharmaceuticals (TERN) | 654.79% |
TMC the metals (TMC) | 578.95% |
Sandisk (SNDK) | 525.96% |
GRAIL, LLC (GRAL) | 446.91% |
Oklo (OKLO) | 389.54% |
Cogent Biosciences (COGT) | 387.72% |
Bloom Energy (BE) | 386.18% |
Opendoor Technologies (OPEN) | 356% |
IREN (IREN) | 354.32% |
Olema Pharmaceuticals (OLMA) | 348.99% |
Lumentum (LITE) | 328.15% |
Applied Digital (APLD) | 317.45% |
ViaSat (VSAT) | 310.45% |
EchoStar (SATS) | 304.24% |
Aris Mining (ARMN) | 304.23% |
Cipher Mining (CIFR) | 304.13% |
Centrus Energy (LEU) | 292.02% |
Metsera, Inc Common Stock (MTSR) | 291.67% |
Aura Minerals Inc Common Shares (AUGO) | 284.58% |
CommScope (COMM) | 278.9% |
